Moderna, Inc. Common Stock (MRNA) Price and Market Data
Explore real-time Moderna, Inc. Common Stock (MRNA) price, market cap, trading volume, and price changes. View the live price chart and key reference data.
Moderna, Inc. Common Stock price chart
Moderna, Inc. is a commercial-stage biotechnology company founded in 2010 that completed its initial public offering in December 2018. The company’s mRNA platform was quickly validated through its COVID-19 vaccine, which received authorization in the United States in December 2020. As of August 2025, Moderna had 35 mRNA development candidates in clinical studies. Its pipeline covers multiple therapeutic areas, including infectious diseases, oncology, cardiovascular disease, and rare genetic disorders.
Reference
- Exchange
- XNAS
- Sector
- BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- Employees
- 4,700
- Listed
- 12/7/2018
- Market cap
- $18.768B
- Shares outstanding
- 394,939,424
- Currency
- usd
- Website
- https://www.modernatx.com